Mice with targeted tyrosine kinase, lyn, disruption
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 12, 1999
Grant Date -
N/A
app pub date -
Oct 18, 1996
filing date -
Oct 18, 1996
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A non-human animal carrying a disruption of a gene encoding a lyn protein tyrosine kinase provides a convenient system for the study of diseases associated with or caused by lyn deficiency, and for the testing of therapeutic agents for the treatment or prevention of diseases which include autoimmune diseases, allergy, asthma and malignant disease.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully